BDSX Biodesix

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025.

Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

Date: Thursday, September 11, 2025

Location: New York, NY

1x1 meetings only

About Biodesix

Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.

Trademarks: Biodesix, Biodesix Logo, Nodify Lung, and IQLung are trademarks or registered trademarks of Biodesix, Inc.

Contacts:

Media:

Natalie St. Denis



1-720-925-9285

Investors:

Chris Brinzey



1-339-970-2843



EN
05/09/2025

Underlying

BDSXBiodesix

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biodesix

 PRESS RELEASE
Free
BDSX BIODESIX

Biodesix to Report Third Quarter 2025 Financial Results on November 3,...

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 LOUISVILLE, Colo., Oct. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September 30, 2025 after the close of trading on Monday, November 3. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. Listeners can register for the webcast via this . Analysts who wish to participate...

18h / 7m 1 EN
 PRESS RELEASE
Free
BDSX BIODESIX

Biodesix Announces Presentations and Events at the CHEST 2025 Annual M...

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting One year after launch of real-world CLARIFY study, preliminary data from the first 1,000 enrolled patients will be presented LOUISVILLE, Colo., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces educational events, abstracts, and activities at the 2025 CHEST Annual Meeting, October 19-22, in Chicago, Illinois. Biodesix will be presenting data from an interim analysis of the CLARIFY study in a sponsored Learning Theater presentation. Title: Prese...

October 15, 2025 1 EN
 PRESS RELEASE
Free
BDSX BIODESIX

Biodesix Unveils October Lung Health Events in Colorado with the Assoc...

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced three Colorado-based events in October for healthcare professionals and community members to collaborate...

October 6, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
KRNY Kearny Financia...
ASA ASA ... (+10)

InsiderInsights.com Daily Ratings Report: September 23, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

KRNY KEARNY FINANCIAL CORP.
ASA ASA
CULP CULP INC.
MUX MCEWEN MINING INC.
AROC ARCHROCK INC.
BCDA BIOCARDIA
AOUT AMERICAN OUTDOOR BRANDS
BDSX INC.
BUKS BIODESIX
BUTLER NATIONAL CORP
09/24/25 September 24, 2025 1 EN
 PRESS RELEASE
Free
BDSX BIODESIX

Biodesix Announces One-for-Twenty Reverse Stock Split

Biodesix Announces One-for-Twenty Reverse Stock Split LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Monday, September 15, 2025. The Company’s common stock will continue to trade under Biodesix’s existing trading symbol, BDSX, on the Nasdaq Global Market (“Nasdaq”) on a split-adjusted basis when the ...

September 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch